Johnson & Johnson has joined Mayo Clinic in backing neurological pain relief company Nevro, taking the total raised by the company since inception to $105m.
US-based healthcare company Johnson & Johnson´s corporate venturing unit has led a $58m round raised by US based medical device company Nevro.
Johnson & Johnson Development Corporation joined the round, which also included existing corporate backer Mayo Clinic, a US-based medical company, and venture capital firms Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, MPM Capital and Three Arch Partners.
In 2010 Nevro said it had raised $20m of a planned $21m round in a Securities and Exchange Commission filing.…
